Core Insights - Klotho Neurosciences, Inc. is pursuing the acquisition of technologies to enhance brain function, muscle strength, bone health, and other longevity indicators [1] - The company aims to expand its focus beyond neurodegenerative diseases to include complementary technologies that support its anti-aging Klotho platform [2] - Klotho gene is linked to aging and longevity, with its levels declining with age, contributing to various age-related disorders [3] Company Developments - Klotho has initiated the manufacturing and development of its products KLTO-101 and KLTO-202, while also exploring additional treatments for healthy aging [3] - The company is assembling a team of experts to identify key longevity indicators, including evaluating specific genes and proteins related to aging [4] - Klotho's mission is to develop assets that can delay the onset of age-related diseases affecting various organs [4] Business Focus - Klotho Neurosciences specializes in biogenetics, focusing on innovative cell and gene therapies derived from the human Klotho gene to treat neurodegenerative and age-related disorders [4] - The company's portfolio includes proprietary cell and gene therapy programs utilizing DNA and RNA as therapeutics, along with genomics-based diagnostic assays [4]
UPDATED: Klotho Neurosciences, Inc. to Expand Development Programs Beyond Neurology